Coronavirus
-
ImmunityBio Gets FDA Authorisation to Begin Trial of Novel Covid-19 Vaccine Candidate
October 31, 2020 ImmunityBio has secured authorisation from the US Food and Drug Administration (FDA) to commence a phase I clinical study of its novel Covid-19 vaccine candidate, called hAd5-Covid-19....
31 Oct 2020
-
29 Oct 2020
Merck Collaborates with Mammoth Biosciences to Scale New SARS-CoV-2 Test
October 29, 2020 Life Science business to serve as contract manufacturer for Mammoth's new DETECTR BOOSTTM SARS-CoV-2 Reagent Kit — a high-throughput Covid-19 test to be mad...
-
7 Oct 2020
The Native Antigen Company Launches Range of SARS-CoV-2 Specific Antibodies
October 7, 2020 Ten new monoclonal antibodies recognise distinct Spike protein epitopes on SARSCoV-2 Antibodies available are specific for S1, S2 and receptor-binding domain reg...
-
23 Sep 2020
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
September 23, 2020 NEW BRUNSWICK, N.J. – Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ...
-
18 Sep 2020
Integral Molecular Awarded Grant from the Commonwealth of Pennsylvania to Advance COVID-19 Research
September 18, 2020 PHILADELPHIA – Integral Molecular has been awarded $521,723 from the Commonwealth of Pennsylvania to leverage its technologies in the global fight against COVID-19. Integral Molecular is at the forefr...
Join Our Newsletter for Free
